SCHEMBL23913083

SCHEMBL23913083

C/N=C\c1ccc(-c2c(OCc3ccc(Cl)cc3)ccc(-c3cc(C(F)(F)F)nn3C)c2O)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.38
KMT2A Q03164 3/20 0.38
MEN1 O00255 2/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
ALDH1A1 P00352 1/20 0.38
NFKB1 P19838 1/20 0.38
NFKB2 Q00653 1/20 0.38
RELA Q04206 1/20 0.38
MAPT P10636 5/20 0.36
LMNA P02545 3/20 0.36
MAPK1 P28482 2/20 0.36
STIM1 Q13586 1/20 0.36
ORAI1 Q96D31 1/20 0.36
MITF O75030 2/20 0.35
POLB P06746 2/20 0.35
UBE2N P61088 1/20 0.35
TACR2 P21452 1/20 0.35
HTT P42858 2/20 0.35
GAA P10253 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21786416 0.88 SLC6A4 (0.41) STIM1ORAI1PTGS1PTGS2CYP1A2
SCHEMBL21786618 0.85 SMN1; SMN2 (0.38) SMN1; SMN2KMT2AMEN1NPC1RAB9A
SCHEMBL21786621 0.85 ARF6 (0.40) ALDH1A1MAPK1STIM1ORAI1POLB
SCHEMBL21786589 0.85 STIM1 (0.37) KMT2AMEN1ALDH1A1STIM1ORAI1
SCHEMBL22791107 0.84 STIM1 (0.43) STIM1ORAI1
SCHEMBL22791106 0.84 STIM1 (0.38) STIM1ORAI1PTGS1PTGS2CYP1A2
SCHEMBL21786611 0.84 SLC6A4 (0.39) STIM1ORAI1PTGS1PTGS2CYP1A2
SCHEMBL21786465 0.84 SLC6A4 (0.39) STIM1ORAI1PTGS1PTGS2CYP1A2
SCHEMBL30807084 0.84 SLC6A4 (0.39) STIM1ORAI1PTGS1PTGS2CYP1A2
SCHEMBL29653521 0.84 SLC6A4 (0.39) STIM1ORAI1PTGS1PTGS2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210395206-A1 SUBSTITUTED HETEROCYCLES AS c-MYC TARGETING AGENTS NORTHWESTERN UNIVERSITY 2021-12-23 US disclosed
US-11142504-B2 Substituted heterocycles as c-MYC targeting agents NORTHWESTERN UNIVERSITY (US) 2021-10-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210395206-A1 SUBSTITUTED HETEROCYCLES AS c-MYC TARGETING AGENTS MYC, MYCBP, MYCBP2 SMN1; SMN2 4195/4885KMT2A 2062/4885MEN1 1497/4885
US-11142504-B2 Substituted heterocycles as c-MYC targeting agents MYC, MYCBP, MYCBP2 SMN1; SMN2 4195/4885KMT2A 2062/4885MEN1 1497/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.